European Psychiatry

Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?
pp. 366-371(6)
Authors: Dalmau A.; Bergman B.; Brismar B.

Alexithymia and anxiety: compounded relationships? A psychometric study
pp. 372-378(7)
Authors: Berthoz S.; Consoli S.; Perez-Diaz F.; Jouvent R.

Need for support and participation in treatment differences among subgroups of relatives to compulsorily and voluntarily admitted mentally ill individuals
pp. 379-385(7)
Authors: Ostman M.; Hansson L.

Psychometric qualities of the French version of the Heinrichs quality of life rating scale
pp. 386-391(6)
Authors: Simon-Abbadi S.; Guelfi J.D.; Ginestet D.

The development and validation of a Spanish version of the quality of life in depression scale (QLDS)
pp. 392-398(7)
Authors: Cervera-Enguix S.; Ramirez N.; Girala N.; McKenna S.P.

Associations between cortical slow potentials and clinical rating scales in panic disorder: a 1.5- year follow-up study
pp. 399-404(6)
Authors: Dengler W.; Wiedemann G.; Pauli P.

Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology
pp. 405-409(5)
Authors: Gervin M.; Browne S.; Garavan J.; Roe M.; Larkin C.; O'Callaghan E.